Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Homozygous Familial Hypercholesterolemia Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Homozygous Familial Hypercholesterolemia Treatmentmarket, defines the market attractiveness level of Homozygous Familial Hypercholesterolemia Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Homozygous Familial Hypercholesterolemia Treatment industry, describes the types of Homozygous Familial Hypercholesterolemia Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Homozygous Familial Hypercholesterolemia Treatment market and the development prospects and opportunities of Homozygous Familial Hypercholesterolemia Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Homozygous Familial Hypercholesterolemia Treatment market in Chapter 13.
By Player:
Gemphire Therapeutics Inc
Regeneron Pharmaceuticals Inc
Daewoong Co Ltd
LipimetiX Development Inc
RegenxBio Inc
The Medicines Company
CymaBay Therapeutics Inc
By Type:
AEM-2802
AEM-2814
Alirocumab
Evinacumab
Others
By End-User:
Clinic
Hospital
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Homozygous Familial Hypercholesterolemia Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Homozygous Familial Hypercholesterolemia Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Homozygous Familial Hypercholesterolemia Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Homozygous Familial Hypercholesterolemia Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Homozygous Familial Hypercholesterolemia Treatment Market Analysis and Outlook to 2022
-
7.1 Global Homozygous Familial Hypercholesterolemia Treatment Consumption (2017-2022)
-
7.2 United States Homozygous Familial Hypercholesterolemia Treatment Consumption (2017-2022)
-
7.3 Europe Homozygous Familial Hypercholesterolemia Treatment Consumption (2017-2022)
-
7.4 China Homozygous Familial Hypercholesterolemia Treatment Consumption (2017-2022)
-
7.5 Japan Homozygous Familial Hypercholesterolemia Treatment Consumption (2017-2022)
-
7.6 India Homozygous Familial Hypercholesterolemia Treatment Consumption (2017-2022)
-
7.7 South Korea Homozygous Familial Hypercholesterolemia Treatment Consumption (2017-2022)
8 Region and Country-wise Homozygous Familial Hypercholesterolemia Treatment Market Analysis and Outlook to 2028
-
8.1 Global Homozygous Familial Hypercholesterolemia Treatment Consumption Forecast (2022-2028)
-
8.2 United States Homozygous Familial Hypercholesterolemia Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Homozygous Familial Hypercholesterolemia Treatment Consumption Forecast (2022-2028)
-
8.4 China Homozygous Familial Hypercholesterolemia Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Homozygous Familial Hypercholesterolemia Treatment Consumption Forecast (2022-2028)
-
8.6 India Homozygous Familial Hypercholesterolemia Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Homozygous Familial Hypercholesterolemia Treatment Consumption Forecast (2022-2028)
9 Global Homozygous Familial Hypercholesterolemia Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Homozygous Familial Hypercholesterolemia Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global AEM-2802 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global AEM-2814 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Alirocumab Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Evinacumab Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Homozygous Familial Hypercholesterolemia Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Homozygous Familial Hypercholesterolemia Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Homozygous Familial Hypercholesterolemia Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global AEM-2802 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global AEM-2814 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Alirocumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Evinacumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Homozygous Familial Hypercholesterolemia Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Homozygous Familial Hypercholesterolemia Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Homozygous Familial Hypercholesterolemia Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Homozygous Familial Hypercholesterolemia Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Homozygous Familial Hypercholesterolemia Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Homozygous Familial Hypercholesterolemia Treatment Market Competitive Analysis
-
14.1 Gemphire Therapeutics Inc
-
14.1.1 Gemphire Therapeutics Inc Company Details
-
14.1.2 Gemphire Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Gemphire Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Product and Service
-
14.2 Regeneron Pharmaceuticals Inc
-
14.2.1 Regeneron Pharmaceuticals Inc Company Details
-
14.2.2 Regeneron Pharmaceuticals Inc Homozygous Familial Hypercholesterolemia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Regeneron Pharmaceuticals Inc Homozygous Familial Hypercholesterolemia Treatment Product and Service
-
14.3 Daewoong Co Ltd
-
14.3.1 Daewoong Co Ltd Company Details
-
14.3.2 Daewoong Co Ltd Homozygous Familial Hypercholesterolemia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Daewoong Co Ltd Homozygous Familial Hypercholesterolemia Treatment Product and Service
-
14.4 LipimetiX Development Inc
-
14.4.1 LipimetiX Development Inc Company Details
-
14.4.2 LipimetiX Development Inc Homozygous Familial Hypercholesterolemia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 LipimetiX Development Inc Homozygous Familial Hypercholesterolemia Treatment Product and Service
-
14.5 RegenxBio Inc
-
14.5.1 RegenxBio Inc Company Details
-
14.5.2 RegenxBio Inc Homozygous Familial Hypercholesterolemia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 RegenxBio Inc Homozygous Familial Hypercholesterolemia Treatment Product and Service
-
14.6 The Medicines Company
-
14.6.1 The Medicines Company Company Details
-
14.6.2 The Medicines Company Homozygous Familial Hypercholesterolemia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 The Medicines Company Homozygous Familial Hypercholesterolemia Treatment Product and Service
-
14.7 CymaBay Therapeutics Inc
-
14.7.1 CymaBay Therapeutics Inc Company Details
-
14.7.2 CymaBay Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 CymaBay Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Homozygous Familial Hypercholesterolemia Treatment
-
Figure Homozygous Familial Hypercholesterolemia Treatment Picture
-
Table Global Homozygous Familial Hypercholesterolemia Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Homozygous Familial Hypercholesterolemia Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Homozygous Familial Hypercholesterolemia Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Homozygous Familial Hypercholesterolemia Treatment Consumption by Country (2017-2022)
-
Figure United States Homozygous Familial Hypercholesterolemia Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Homozygous Familial Hypercholesterolemia Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Homozygous Familial Hypercholesterolemia Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Homozygous Familial Hypercholesterolemia Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Homozygous Familial Hypercholesterolemia Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Homozygous Familial Hypercholesterolemia Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Homozygous Familial Hypercholesterolemia Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Homozygous Familial Hypercholesterolemia Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Homozygous Familial Hypercholesterolemia Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Homozygous Familial Hypercholesterolemia Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Homozygous Familial Hypercholesterolemia Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Homozygous Familial Hypercholesterolemia Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Homozygous Familial Hypercholesterolemia Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AEM-2802 Consumption and Growth Rate (2017-2022)
-
Figure Global AEM-2814 Consumption and Growth Rate (2017-2022)
-
Figure Global Alirocumab Consumption and Growth Rate (2017-2022)
-
Figure Global Evinacumab Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global AEM-2802 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AEM-2814 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alirocumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Evinacumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Homozygous Familial Hypercholesterolemia Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Homozygous Familial Hypercholesterolemia Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Gemphire Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Gemphire Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gemphire Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Product and Service
-
Table Regeneron Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Regeneron Pharmaceuticals Inc Homozygous Familial Hypercholesterolemia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regeneron Pharmaceuticals Inc Homozygous Familial Hypercholesterolemia Treatment Product and Service
-
Table Daewoong Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Daewoong Co Ltd Homozygous Familial Hypercholesterolemia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daewoong Co Ltd Homozygous Familial Hypercholesterolemia Treatment Product and Service
-
Table LipimetiX Development Inc (Foundation Year, Company Profile and etc.)
-
Table LipimetiX Development Inc Homozygous Familial Hypercholesterolemia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table LipimetiX Development Inc Homozygous Familial Hypercholesterolemia Treatment Product and Service
-
Table RegenxBio Inc (Foundation Year, Company Profile and etc.)
-
Table RegenxBio Inc Homozygous Familial Hypercholesterolemia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table RegenxBio Inc Homozygous Familial Hypercholesterolemia Treatment Product and Service
-
Table The Medicines Company (Foundation Year, Company Profile and etc.)
-
Table The Medicines Company Homozygous Familial Hypercholesterolemia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table The Medicines Company Homozygous Familial Hypercholesterolemia Treatment Product and Service
-
Table CymaBay Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table CymaBay Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table CymaBay Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Product and Service
-
